EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Perioperative Administration of Tranexamic Acid and Low Molecular Weight Heparin for Enhanced Blood Management in Intertrochanteric Fractures: A Randomized Controlled Study

Chunyong Zhu, Zhongqing Ji, Jiangfeng Zhu, Hao Xu, Shiyan Li, Chuancheng Liu, Bin Wei

Medical Science Monitor · 2024

DOI: 10.12659/msm.944063 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Medical Science Monitor, 2024. Verfasst von Chunyong Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Suzhou Yongding Hospital, Suzhou, Jiangsu, China (mainland). Hauptthemen laut MEDLINE: Tranexamic Acid, Hip Fractures, Heparin, Low-Molecular-Weight, Blood Loss, Surgical. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND This prospective study from a single center aimed to compare the perioperative blood loss (PBL) in 79 patients with intertrochanteric fractures (IF) treated with intramedullary nailing (IMN) using 3 regimens of combined tranexamic acid (TXA) and low molecular weight heparin (LMWH), proposing a novel therapy of 4-dose TXA. MATERIAL AND METHODS We recruited 79 patients and randomly divided them into 3 groups. The 4-dose TXA group (22 patients) received 1.0 g intravenous TXA 30 min before surgery and 1.0 g at intervals of 3, 6, and 9 h before surgery. The 1-dose TXA group (25 patients) received 1.0 g intravenous TXA 30 min before surgery, while the control group (32 patients) did not receive TXA. LMWH was applied 12 h after surgery in each group. The primary metrics evaluated included hidden blood loss (HBL), total blood loss (TBL), and the number and incidence rate of deep vein thrombosis (DVT). RESULTS Analysis of the HBL revealed that the 4-dose TXA group had the lowest average (583.13±318.08 ml), followed by the 1-dose TXA group (902.94±509.99 ml), and the control group showed the highest (1154.39±452.06 ml) (P 0.05). CONCLUSIONS Treatment using 4-dose TXA and LMWH can effectively reduce PBL without increasing the DVT risk in IF patients with IMN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidHip FracturesHeparin, Low-Molecular-WeightBlood Loss, SurgicalVenous ThrombosisHumansFemaleMaleAgedProspective StudiesMiddle AgedPerioperative CareAntifibrinolytic AgentsAged, 80 and overFracture Fixation, Intramedullary

Substanzen

Tranexamic AcidHeparin, Low-Molecular-WeightAntifibrinolytic Agents

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Suzhou Yongding Hospital, Suzhou, Jiangsu, China (mainland).

Zitieren

APA

Zhu, C., Ji, Z., Zhu, J., Xu, H., Li, S., Liu, C., & Wei, B. (2024). Perioperative Administration of Tranexamic Acid and Low Molecular Weight Heparin for Enhanced Blood Management in Intertrochanteric Fractures: A Randomized Controlled Study. Medical Science Monitor. https://doi.org/10.12659/msm.944063

Vancouver

Zhu C, Ji Z, Zhu J, Xu H, Li S, Liu C, et al. Perioperative Administration of Tranexamic Acid and Low Molecular Weight Heparin for Enhanced Blood Management in Intertrochanteric Fractures: A Randomized Controlled Study. Medical Science Monitor. 2024. doi:10.12659/msm.944063

BibTeX
@article{Zhu2024,
  author = {Zhu, Chunyong and Ji, Zhongqing and Zhu, Jiangfeng and Xu, Hao and Li, Shiyan and Liu, Chuancheng and Wei, Bin},
  title = {Perioperative Administration of Tranexamic Acid and Low Molecular Weight Heparin for Enhanced Blood Management in Intertrochanteric Fractures: A Randomized Controlled Study},
  journal = {Medical Science Monitor},
  year = {2024},
  doi = {10.12659/msm.944063}
}
Kostenlos starten →